Panacea Biotec Announces Resignation of Independent Director Rajesh Jain
Panacea Biotec Ltd. announced that CA Rajesh Jain, a non-executive independent director, has resigned from his position, effective June 30, 2026. Jain’s resignation also extends to his role as an independent director of Panacea Biotec Pharma Ltd., a material wholly owned subsidiary.The decision is attributed to existing professional commitments and increasing time demands related to evolving regulatory and corporate governance requirements, which Jain stated would limit his ability to dedicate the necessary time and attention to the role.
CA Rajesh Jain will also cease to be the Chairman/member of the Committees of the Board of Directors of the Company and Panacea Biotec Pharma Ltd. as of June 30, 2026
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.